Showing results (151-160 of 1,736) with videos related to
Sort By:
Pageof 174
Harm Reduction Journal|June 9, 2025
A novel naloxone distribution intervention among persons experiencing unsheltered homelessness: acceptability of naloxone training and distribution during an annual point-in-time countAshleigh Herrera, Kael RiosHarm Reduction Journal|July 18, 2025
The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in GermanySimon Fleißner, Larissa Steimle, Dirk Schäffer, et al.Harm Reduction Journal|July 18, 2025
"I think that that really could benefit a lonely user:" perceptions of overdose response hotlines among people who use opioidsRachel E Gicquelais, Rachel P Chenoweth, Nora Jacobson, et al.Harm Reduction Journal|October 8, 2025
The potential use of digital technologies to enhance opioid agonist treatment in rural and remote communities of British Columbia, CanadaAmreetha Jayathilake, Kate Hodgson, Manal Mansoor, et al.Harm Reduction Journal|October 4, 2025
Harm reduction practises for users of psychedelic drugs: a scoping reviewCarissa Dutton, Emily North, Ylona Chun Tie, et al.Harm Reduction Journal|July 9, 2025
Qualitative insights into drug use safety strategies and social support among sexual minority women who inject drugs in Baltimore, MarylandJennifer L Glick, Leanne Zhang, Aimee Huang, et al.Harm Reduction Journal|July 18, 2025
Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial surveyFarihah Ali, Cayley Russell, Justine Law, et al.Harm Reduction Journal|July 4, 2025
Understanding drug-related harms as risk-amplifying loops among people who inject drugs in SwedenJessica Storbjörk, Eva Samuelsson, Josefin Månsson, et al.Harm Reduction Journal|January 6, 2026
Energy drink consumption among Kabul University students: a cross-sectional study of prevalence, patterns, awareness, and adverse health effectsErshad Ahmad Mushkani, Fahima Hamidy, Tawfiq Ahmad Mushkani, et al.Harm Reduction Journal|December 20, 2025
Fentanyl, Amphetamine-type Stimulants, Heroin, and xylazine in drug residues in two Northern border Mexican citiesClara Fleiz Bautista, María Elena Medina-Mora, Silvia L Cruz, et al.Pageof 174